RFA
Resurgent Financial Advisors’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-402
| Closed | -$25.2K | – | 249 |
|
|
2023
Q4 | $25.2K | Buy |
+402
| New | +$25.2K | 0.02% | 449 |
|
|
2023
Q3 | – | Sell |
-412
| Closed | -$23.1K | – | 489 |
|
|
2023
Q2 | $23.1K | Buy |
+412
| New | +$23.1K | 0.02% | 468 |
|
|
2023
Q1 | – | Sell |
-4,912
| Closed | -$200K | – | 511 |
|
|
2022
Q4 | $200K | Sell |
4,912
-240
| -5% | -$9.76K | 0.11% | 202 |
|
|
2022
Q3 | $336K | Buy |
5,152
+431
| +9% | +$28.1K | 0.22% | 118 |
|
|
2022
Q2 | $287K | Buy |
4,721
+451
| +11% | +$27.4K | 0.18% | 136 |
|
|
2022
Q1 | $268K | Buy |
+4,270
| New | +$268K | 0.17% | 135 |
|